Related Experiment Video
Updated: Jun 20, 2026
15:04
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Structure activity relationship of antiproliferative agents using multiple linear regression
Leyte L Winfield1, Tasha R Inniss, Dayle M Smith
1Spelman College, Atlanta, GA 30314, USA. lwinfield@spelman.edu
Chemical Biology & Drug Design
|August 26, 2009
Summary
This study developed a Quantitative Structure-Activity Relationship (QSAR) model to predict the antiproliferative activity of celecoxib analogs. This model aids in designing new cancer chemotherapeutic agents, particularly for prostate cancer.
Area of Science:
- Medicinal Chemistry
- Oncology
- Computational Chemistry
Background:
- Cancer remains a leading cause of death, necessitating novel chemotherapeutic agents.
- Celecoxib, an FDA-approved drug, shows antiproliferative effects against various tumors.
- Its mechanisms involve both cyclooxygenase-2 dependent and independent pathways.
Purpose of the Study:
- To develop a Quantitative Structure-Activity Relationship (QSAR) model for predicting antiproliferative activity.
- To underscore the structural significance of celecoxib as a lead compound for anticancer drug development.
- To identify novel antiproliferative agents based on celecoxib's structure.
Main Methods:
- A structure-based approach was utilized.
- A library of celecoxib analogs was synthesized and evaluated.
- QSAR modeling was employed to correlate structural features with antiproliferative activity.
Main Results:
- A predictive QSAR model for antiproliferative activity was successfully developed.
- The model highlights key structural determinants of celecoxib's efficacy.
- Insights into structure-activity relationships were gained for designing new agents.
Conclusions:
- The developed QSAR model can predict the antiproliferative potential of novel molecules.
- This approach facilitates the rational design of targeted cancer chemotherapeutics.
- Celecoxib serves as a valuable scaffold for developing new anticancer drugs.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:25Multiple Regression
Multiple regression assesses a linear relationship between one response or dependent variable and two or more independent variables. It has many practical applications.
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...